Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-04-25 ¸ñ 08:51
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 1,514°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Interview]
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù°, ACEI Ä¡·á°æÇèÀÌ ¾ø´Â ȯÀÚ¿¡°Ô Æ丰µµÇÁ¸±À» Åõ¿©ÇÏ¸é ±âÀú½ÃÁ¡(baseline) ´ëºñ...
ÀÌ»óµ· ±âÀÚ
|
2024-03-15 16:42
¶óÀÎ
[Sub Story]
Çѱ¹ÀÎ ¹ÝÀÀ·ü °í·ÁÇϸé Áß°µµ ÃæºÐÈ÷ È¿°úÀû
µ¿¹ÝÁúȯÀÌ»óÁöÁúÇ÷ÁõÀº ´ç´¢º´ ȯÀÚÀÇ ´ëÇ÷°üÇÕº´Áõ ¿¹¹æÀ» À§ÇØ ¹Ýµå½Ã Àâ¾Æ¾ß ÇÏ´Â ½ÉÇ÷°üÁúȯ À§ÇèÀÎÀÚ Áß Çϳª·Î Áö¸ñµÇ°í ÀÖ´Ù. ±× ¸¸Å...
ÀÌ»óµ· ±âÀÚ
|
2024-03-15 16:24
¶óÀÎ
[Journal Briefing]
Ç÷´ç°ÇÏÁ¦ º´¿ë, ½ÉÇ÷°ü¡¤½ÅÀå ÇýÅà ½Ã»ç
Ç÷´ç°ÇÏÁ¦ º´¿ë¿ä¹ýÀÌ Áß°µµ ÀÌ»óÀÇ ´Ü¹é´¢¸¦ µ¿¹ÝÇÑ 2Çü´ç´¢º´ ȯÀÚ¿¡¼ ½ÉÇ÷°ü¡¤½ÅÀå ÇýÅðú ¿¬°ü¼ºÀ» º¸¿´´Ù´Â ¿¬±¸°á°ú°¡ Circulation¿¡ °ÔÀçµÆ´Ù. ¹Ì±¹ ÇϹöµåÀÇ´ë Muthiah Vaduganathan ±³¼öÆÀÀº...
Á¤¿¬ÁÖ ±âÀÚ
|
2024-03-15 15:44
¶óÀÎ
[Journal Briefing]
´ÙÆı۸®Ç÷ÎÁø ¸®¾ó¿ùµå¿¡¼µµ ½ÅÀåÇýÅà °Åµì È®ÀÎ
´ÙÆı۸®Ç÷ÎÁø Ä¡·á°¡ ¾ËºÎ¹Î´¢¸¦ µ¿¹ÝÇÑ 2Çü´ç´¢º´ ȯÀÚÀÇ ½ÅÀå±â´É ¾Æ¿ôÄÄÀ» °³¼±½ÃÄ×´Ù´Â ¿¬±¸°á°ú°¡ ¹ßÇ¥µÆ´Ù. ÀÌ´Â DARWIN-RenalÀÇ Èļӿ¬±¸ °á°ú·Î, ´ÙÆı۸®Ç÷ÎÁø°ú ´Ù¸¥ Ç÷´ç°ÇÏÁ¦ Åõ¿©½Ã ½ÅÀå ¾Æ¿ôÄÄÀ» Àå±â...
Á¤¿¬ÁÖ ±âÀÚ
|
2024-03-15 15:42
¶óÀÎ
[Interview]
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â?´çÈÇ÷»ö¼Ò(A1C)¿¡ ±Ù°ÅÇÑ SGLT-2¾ïÁ¦Á¦(SGLT-2i)ÀÇ Ç÷´çÁ¶Àý È¿°ú¿¡ ´ëÇØ ±¹³»...
ÀÌ»óµ· ±âÀÚ
|
2024-03-15 15:30
¶óÀÎ
[Sub Story]
Ç×°íÇ÷¾ÐÁ¦ º´¿ë¿ä¹ý
¡â´Ù¾çÇÑ º´Å»ý¸®¡â¸ñÇ¥Ç÷¾Ð °È¿¡¼ ±âÀÎ
´Ù¾çÇÑ º´Å»ý¸®Ç×°íÇ÷¾ÐÁ¦ º´¿ë¿ä¹ýÀÇ ÀÌ·ÐÀû ¹è°æÀº °íÇ÷¾ÐÀÇ º´Å»ý¸®¿¡¼ ´äÀ» ãÀ» ¼ö ÀÖ´Ù. °íÇ÷¾ÐÀº RAS(·¹´Ñ¡¤¾ÈÁö¿ÀÅٽŽýºÅÛ)¾ïÁ¦...
ÀÌ»óµ· ±âÀÚ
|
2024-03-14 17:57
¶óÀÎ
[Interview]
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?Çѱ¹ÁöÁú¡¤µ¿¸Æ°æÈÇÐȸ Áø·áÁöħ¿¡¼ °ü»óµ¿¸ÆÁúȯ(CAD) º´·ÂÀÚÀÇ LDLÄÝ·¹½ºÅ×·Ñ(LDL-C)...
ÀÌ»óµ· ±âÀÚ
|
2024-03-14 17:41
¶óÀÎ
[Clinical Update]
NAFLD & ºñ¸¸¡¤´ç´¢º´ µ¿¹ÝÀÌȯ °¡´É¼º Çö½Ç·Î
¹ß»ý·ü´ëÇÑ°£ÇÐȸÀÇ °£Áúȯ¹é¼(2023³â)¿¡ µû¸£¸é, ¿¬±¸¹æ¹ý°ú Áø´Ü±âÁØ¿¡ µû¶ó Â÷À̸¦ º¸ÀÌÁö¸¸ NAFLD ¹ß»ý·üÀº 1000¸í´ç ¿¬°£ 2...
ÀÌ»óµ· ±âÀÚ
|
2024-03-13 15:20
¶óÀÎ
[Drug Review]
ÄÉ·»µð¾ÆÁ¤ Çã°¡¡¤±Þ¿©·Î
2Çü´ç´¢º´ µ¿¹Ý ¸¸¼º½ÅÀ庴 Ä¡·á ¿ÏÀüü °¡µ¿
2Çü´ç´¢º´ µ¿¹Ý ¸¸¼º½ÅÀ庴¸¸¼º½ÅÀåÁúȯ(CKD, chronic kidney disease)Àº ¼Òº¯ ¾ËºÎ¹Î ¼öÄ¡(UACR, ¾ËºÎ¹Î-Å©·¹¾ÆƼ...
ÀÌ»óµ· ±âÀÚ
|
2024-03-13 14:56
¶óÀÎ
[Sub Story]
Ç×°íÇ÷¾ÐÁ¦+½ºÅ¸Æ¾ º´¿ëÄ¡·á´Â ±Ù°ÅÁß½ÉÀÇÇÐ ´ëÇ¥»ç·Ê
´ë»çÁõÈıº°íÇ÷¾ÐÀÌ ÀÌ»óÁöÁúÇ÷Áõ ¿Ü¿¡µµ °íÇ÷´ç¡¤º¹ºÎºñ¸¸ µî ¿©Å¸ ½ÉÇ÷°üÁúȯ À§ÇèÀÎÀÚ¿Í µ¿¹ÝµÅ »óÈ£ÀÛ¿ëÇÏ¸ç ½ÉÇ÷°üÁúȯ À§ÇèÀ» ´õ Áõ°¡½ÃŲ´Ù...
ÀÌ»óµ· ±âÀÚ
|
2024-03-13 14:48
¶óÀÎ
[Late Breaking Studies]
ÇÇŸ¹Ù½ºÅ¸Æ¾, Á׻󵿸ưæÈÁõ ÅðÇà °¡´É¼º ½Ã»ç
REPRIEVE ÇÏÀ§ºÐ¼®À̹ø ÇÏÀ§ºÐ¼®Àº 2015~2018³â ¹Ì±¹ 31°³ ¿¬±¸±â°ü¿¡¼ ÁøÇàµÈ ¹«ÀÛÀ§¡¤´ëÁ¶±º ÀÓ»ó½ÃÇèÀÎ REPRIEVE ¸ð...
Á¤¿¬ÁÖ ±âÀÚ
|
2024-03-13 14:32
¶óÀÎ
[Interview]
¡°1Â÷ÀÇ·á ´Ü°è¼ºÎÅÍ ´ç´¢º´¼º ½ÅÀåÁúȯ ½Ï ã¾Æ³» À߶ó³»ÀÚ¡±
Q. °¡À̵å¶óÀο¡¼ SGLT-2i´Â ¾î¶»°Ô ±Ç°íµÇ³ª?´ëÇÑ´ç´¢º´ÇÐȸ Áø·áÁöħ¿¡¼´Â ´çÈÇ÷»ö¼Ò(A1C) ¼öÄ¡¿¡ ±Ù°ÅÇÏ´Â ¡âÇ÷´çÁ¶Àý »Ó ¾Æ´Ï...
ÀÌ»óµ· ±âÀÚ
|
2024-03-13 14:15
¶óÀÎ
[Sub Story]
Çѱ¹ÀÎ ´ç´¢º´ º´Å»ý¸®´Â ºñºö¹äÇü
Àν¶¸°ºÐºñ´É2Çü´ç´¢º´ º´Å»ý¸®ÀÇ ´Ù¾ç¼º¿¡ µû¶ó Àν¶¸°ÀúÇ×¼ºÀº ¹°·Ð Àν¶¸°ºÐºñ´ÉÀ» °³¼±ÇÏ´Â ±âÀüÀÇ ¾àÁ¦±îÁö ¾î´À °Í Çϳª °£°úÇÒ ¼ö ¾ø´Ù...
ÀÌ»óµ· ±âÀÚ
|
2024-03-12 15:41
¶óÀÎ
[Sub Story]
½ºÅ¸Æ¾, ½ÉÇ÷°üÁúȯ 2Â÷¿¹¹æ¿¡ ±â¿©
100mg/dL → 70mg/dLÁö±ÝÀÌ¾ß 55mg/dL ¹Ì¸¸±îÁö ³»·Á¿ÔÁö¸¸, ½ÉÇ÷°üÁúȯ º´·ÂÀÚ µî ÃÊ°íÀ§Ç豺ÀÇ 2Â÷¿¹¹æÀ» À§ÇØ...
ÀÌ»óµ· ±âÀÚ
|
2024-03-12 14:52
¶óÀÎ
[Interview]
¡°°íÇ÷¾Ð¡¤ÀÌ»óÁöÁúÇ÷Áõ µ¿¹ÝÄ¡·á SPC Àü·«À¸·Î À¯È¿¼º¡¤¼øÀÀµµ Á¦°í¡±
Q. °íÇ÷¾Ð°ú ÀÌ»óÁöÁúÇ÷ÁõÀÇ µ¿¹ÝÀÌȯÀ²Àº?´ëÇÑ°íÇ÷¾ÐÇÐȸÀÇ Korea Hypertension Fact Sheet 2023¿¡ µû¸£¸é, 20...
ÀÌ»óµ· ±âÀÚ
|
2024-03-12 14:41
¶óÀÎ
[Interview]
¡°Áö¹æ°£¡¤¼¶À¯È ÇýÅà º¸°íÀÚ ´Ù±â°ü¡¤ÀüÇâÀû RCT ÁøÇàÁß¡±
Q. NAFLD, ¿Ö À§ÇèÇÑ°¡?¿ì¼± ±¹³»¿¡¼ ºñ¾ËÄڿüº Áö¹æ°£Áúȯ(NAFLD)ÀÇ À¯º´·üÀÌ ´Ã°í ÀÖ´Ù´Â °ÍÀÌ ¹®Á¦´Ù. ´ëÇÑ°£ÇÐȸÀÇ º¸°í¼...
ÀÌ»óµ· ±âÀÚ
|
2024-03-12 11:57
¶óÀÎ
[Cover Story]
Çѱ¹ÀÎ ¸¸¼ºÁúȯÀº ¿ë±¤·Î¡¤ºñºö¹äÀÌÀÚ º¹ÇÕÇü
K-¸¸¼ºÁúȯÁö±Ý±îÁö ¾ð±ÞÇÑ ³»¿ëÀº ¸¸¼ºÁúȯÀÇ ÀϹÝÀûÀÎ º´Å»ý¸®¸¦ ¾ð±ÞÇÑ °ÍÀÌ´Ù. ÇÏÁö¸¸ ¸¸¼ºÁúȯÀº Áö¿ª¡¤ÀÎÁ¾º°·Î Â÷À̸¦ ³ªÅ¸³»±âµµ ÇÑ´Ù...
ÀÌ»óµ· ±âÀÚ
|
2024-03-12 09:08
¶óÀÎ
[Journal Briefing]
¿¬ 2ȸ ÁÖ»ç·Î LDL-C ¸ñǥġ¿¡ Çѹߦ ´õ
Çѱ¹Àο¡¼µµ ¿¬ 2ȸ ÁÖ»ç·Î LDLÄÝ·¹½ºÅ×·Ñ(LDL-C) Á¶ÀýÈ¿°ú¸¦ º¼ ¼ö ÀÖÀ» °ÍÀ¸·Î Àü¸ÁµÈ´Ù. À̹ø ORION-18 ¿¬±¸¿¡¼´Â Á׻󵿸ưæȼº ½ÉÇ÷°üÁúȯ(ASCVD) ¶Ç´Â ASCVD °íÀ§ÇèÀÌ¸é¼ LDL-C°¡ ³ôÀº ...
Á¤¿¬ÁÖ ±âÀÚ
|
2024-03-08 09:44
¶óÀÎ
[Journal Briefing]
3Á¦º¹ÇÕÁ¦, Ç÷¾Ð¡¤ÁöÁú °³¼±È¿°ú ´Üµ¶º¸´Ù ¿ì¼ö
ÀÌ»óÁöÁúÇ÷Áõ°ú °íÇ÷¾ÐÀ» µ¿¹ÝÇÑ È¯ÀÚ¿¡¼ 3Á¦ º¹ÇÕÁ¦°¡ 2Á¦ ¶Ç´Â ´ÜÀÏÁ¦º¸´Ù Ç÷¾Ð°ÇÏ ¹× ÁöÁú°³¼± È¿°ú°¡ ¿ì¼öÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù. ÀÌÀü ¿¬±¸¿¡¼´Â 2Á¦ º´¿ë¿ä¹ý(·Î¼ö¹Ù½ºÅ¸Æ¾ + ¿¡Á¦Æ¼¹Ìºê)°ú ½ºÅ¸Æ¾ ´Üµ¶¿ä¹ýÀ» ºñ±³ÇÑ ...
Á¤¿¬ÁÖ ±âÀÚ
|
2024-02-20 11:01
¶óÀÎ
[Journal Briefing]
½ÉºÎÀü Åð¿øÈÄ ´Ü±â°£¿¡ ¾à¹°Ä¡·á ÃÖÀû¿ë·® µµ´ÞÇؾß
½ÉºÎÀü ȯÀÚ°¡ Åð¿ø ÈÄ 2ÁÖ°¿¡ °í¿ë·®¿¡ µµ´ÞÇÏ´Â °ÍÀÌ ±àÁ¤ÀûÀÎ ¿¹Èĸ¦ ³ªÅ¸³½ °ÍÀ¸·Î º¸°íµÆ´Ù. ÀÌ´Â STRONG-HF ¿¬±¸ÀÇ 2Â÷ºÐ¼® °á°ú·Î, ½ÉºÎÀü ȯÀÚ °¡¿îµ¥ ÁýÁßÄ¡·á±º¿¡¼ °¡À̵å¶óÀÎ ±â¹Ý ¾à¹°Ä¡·á(GDMT)ÀÇ...
Á¤¿¬ÁÖ ±âÀÚ
|
2024-02-16 10:10
-
1
2
3
4
5
6
7
8
9
10
´ÙÀ½
-
¿©¹é
Sub
news
¡°Á¹·¹µå·Î³×ÀÌÆ® °ñÀý¿¹¹æ ÀÓ»ó±Ù°Å¡¤ÀûÀÀÁõ ÃÖ´Ù¡±
Q. °ñÀý¿¹¹æÀ» À§ÇÑ ¾à¹°Ä¡·á´Â ¾î¶»°Ô ±Ç°í...
¡°CGM ¿¬µ¿ Àν¶¸°¿ä¹ý °í³µµ ±â¼úÀû Áö½Ä ¿äÇÏ´Â Ä¡·á°úÁ¤¡±
Q. ´ç´¢º´ Ä¡·á½Ã CGM ÀÓ»óÀû ¿ªÇÒÀº?ÀÓ...
¡°·Î¼ö¹Ù½ºÅ¸Æ¾ 20³â ±Ù°Å·Î ¼öÆÛ½ºÅ¸Æ¾ ¸í¼º À¯ÁöÇÒ °Í¡±
Q. ´ç´¢º´ ȯÀÚ¿¡¼ ÁöÁúÄ¡·á°¡ ÇÊ¿äÇÑ ÀÌÀ¯...
¿©¹é
¿©¹é
Back to Top